Urska Kamensek

Ljubljana, Slovenia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Luciferase-induced immune activation prevents orthotopic K7M2luc osteosarcoma establishment in BALB/c mice.

Luciferase-induced immune activation prevents orthotopic K7M2luc osteosarcoma establishment in BALB/c mice.

Journal: Radiology and oncology
Published: August 17, 2026

Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. Cancers 2022, 14, 1630.

Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. Cancers 2022, 14, 1630.

Journal: Cancers
Published: February 27, 2026

Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancer.

Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancer.

Journal: Cancer letters
Published: June 08, 2025

Editorial on Special Issue "Plasmid DNA for Gene Therapy and DNA Vaccine Applications".

Editorial on Special Issue "Plasmid DNA for Gene Therapy and DNA Vaccine Applications".

Journal: Pharmaceutics
Published: April 30, 2025

Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy.

Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy.

Journal: Dalton transactions (Cambridge, England : 2003)
Published: February 19, 2025

Antitumor Efficacy of Interleukin 12-Transfected Mesenchymal Stem Cells in B16-F10 Mouse Melanoma Tumor Model.

Antitumor Efficacy of Interleukin 12-Transfected Mesenchymal Stem Cells in B16-F10 Mouse Melanoma Tumor Model.

Journal: Pharmaceutics
Published: December 23, 2024

Palladium(II)-Indenyl Complexes Bearing N-Heterocyclic Carbene (NHC) Ligands as Potent and Selective Metallodrugs toward High-Grade Serous Ovarian Cancer Models.

Palladium(II)-Indenyl Complexes Bearing N-Heterocyclic Carbene (NHC) Ligands as Potent and Selective Metallodrugs toward High-Grade Serous Ovarian Cancer Models.

Journal: Journal of medicinal chemistry
Published: August 09, 2024

Electrochemotherapy with bleomycin, oxaliplatin, or cisplatin in mouse tumor models, from tumor ablation to in situ vaccination.

Electrochemotherapy with bleomycin, oxaliplatin, or cisplatin in mouse tumor models, from tumor ablation to in situ vaccination.

Journal: Frontiers in immunology
Published: July 25, 2024

Non-clinical evaluation of pmIL12 gene therapy for approval of the phase I clinical study.

Non-clinical evaluation of pmIL12 gene therapy for approval of the phase I clinical study.

Journal: Scientific reports
Published: June 24, 2024

A carrier free delivery system of a MAGL inhibitor is effective on ovarian cancer.

A carrier free delivery system of a MAGL inhibitor is effective on ovarian cancer.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: April 15, 2024

In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells.

In Vitro and In Vivo Evaluation of the Effects of Drug 2c and Derivatives on Ovarian Cancer Cells.

Journal: Pharmaceutics
Published: April 12, 2024

Interleukins and interferons in mesenchymal stromal stem cell-based gene therapy of cancer.

Interleukins and interferons in mesenchymal stromal stem cell-based gene therapy of cancer.

Journal: Cytokine & growth factor reviews
Published: February 05, 2024
Showing 1-12 of 56

Last Updated: 09/26/2026